BEIJING, June 16, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it has obtained a software copyright certificate for its Tele-Consultation Management System V1.0 from China's State Copyright Bureau and has received the software product register and test report from the Software Testing Center of China's State Information Center. The Company is applying for software product registration and software company certification and anticipates receiving such registration and certification near year-end.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical stated, "We are pleased to obtain the software copyright certificate, which will help us diversify business strategies into mobile health and telemedicine. According to state tax incentives granted to companies possessing software copyright, we will receive a preferential value added tax rate of 3% on sales of software, rather than the standard 17% that applies to sales of our other products. Along with the software copyright certificate, software product register and test report, we are in the process of applying for the software product registration and software company certification. When we receive these two certifications, we will become eligible for preferable income tax treatment for a limited time. We are pleased that our efforts in R&D have been recognized and we expect that the tax benefit will improve our competitiveness going forward."
Tele-Consultation Management System V1.0
The Tele-Consultation Management System V1.0 is internet server-based, using the remote network interactive connection to realize real-time video, audio, text, images, and files, using a combination of browser/server and client/server. It isn't limited to a particular operating system or database to realize cross-platform application. Combining hospitals across the country, the system is convenient for local hospitals to effectively solve various problems from tele-consultation. At the same time, patients can remain near home and still have access to national experts who can assist local hospitals with diagnosis and treatment.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and ten software copyrights. More information can be found at http://www.dehaier.com.cn
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.